Project Number 188 Agency/Funding Organization Alzheimer's Society UK Funding Year 2012 View Full Project Details for Novel drugs for treating Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator Gunn-Moore, Frank Principal Investigator First Name Frank Principal Investigator Last Name Gunn-Moore Awardee Organization University of St. Andrews Contact PI Country United Kingdom Project Detail FY Overall Cost $120,957 Funding Organization Agency/Funding Organization Alzheimer's Society UK Funding Organization Country United Kingdom
